Sign in

CIK 0001453687 · Non-accelerated filer<br>Smaller reporting company

Cartesian Therapeutics, Inc.

Sign in to watch
Ticker
RNAC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
301-348-8698
Business address
7495 NEW HORIZON WAY, FREDERICK, MD, 21703
Former names
SELECTA BIOSCIENCES INC
  1. 4 Grant or award Chief Operations Officer acquired 16,100 shares (grant or award)
  2. 4 Grant or award Chief Financial Officer acquired 22,000 shares (grant or award)
  3. 4 Grant or award Director acquired 2,600 shares (grant or award)
  4. 4 Grant or award Chief Medical Officer acquired 19,000 shares (grant or award)
  5. 4 Grant or award Director acquired 2,600 shares (grant or award)
  6. 4 Grant or award Director acquired 2,600 shares (grant or award)
  7. 4 Grant or award Director acquired 2,600 shares (grant or award)
  8. 4 Grant or award Director acquired 2,600 shares (grant or award)
  9. 4 Grant or award Chief Technology Officer acquired 16,100 shares (grant or award)
  10. 4 Grant or award Director acquired 2,600 shares (grant or award)
  11. 4 Grant or award Director acquired 2,600 shares (grant or award)
  12. 4 Grant or award Director acquired 2,600 shares (grant or award)
  13. 4 Gift Director gave 20,000 shares (gift)
  14. 4 Option exercise SVP, Head of Manufacturing acquired 7,650 shares (option exercise)
  15. 4 Open-market buy Director bought 52,189 shares at an average $18.49 ($965,021)
  16. 4 Open-market sale Chief Technology Officer sold 13,664 shares at an average $25.26 ($345,134)
  17. 4 Open-market sale Chief Technology Officer sold 38,689 shares at an average $16.78 ($649,030)
  18. 4 Gift Director gave 28,821 shares (gift)
  19. 4 Option exercise Chief Scientific Officer acquired 14,000 shares (option exercise)
  20. 4 Open-market buy Director bought 431,940 shares at an average $17.07 ($7,373,527)

Page 3 of 21 · 410 filings